Pregnancy complications in patients with epilepsy

被引:15
|
作者
Borthen, Ingrid [1 ,3 ]
Gilhus, Nils Erik [2 ,3 ]
机构
[1] Haukeland Hosp, Dept Obstet & Gynaecol, N-5021 Bergen, Norway
[2] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway
[3] Univ Bergen, Dept Clin Med, Bergen, Norway
关键词
antiepileptic drugs; delivery; epilepsy; malformations; pregnancy; ANTIEPILEPTIC DRUGS; VALPROIC ACID; IN-UTERO; WOMEN; DELIVERY; MALFORMATIONS; RISK; METAANALYSIS; REGISTRIES; EXPOSURE;
D O I
10.1097/GCO.0b013e32834feb6a
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose of review Epilepsy is a common neurological disorder affecting 0.4-0.8% of pregnant women. Preeclampsia, gestational hypertension, bleeding in pregnancy, induction of labour, caesarean delivery and major congenital malformations of the children occur more frequently in this group. The objective of this review is to evaluate the pregnancy and delivery complications including congenital abnormalities in women with epilepsy. This review comments on results of recently published studies including the Medical Birth Registry of Norway. A second aim of the review is to examine the effect of antiepileptic-drug treatment on pregnancy complications, and also their association with congenital abnormalities associated with these medications. Recent findings Women with epilepsy have a higher risk of preeclampsia, gestational hypertension, bleeding in pregnancy and excessive bleeding postpartum. They also have higher incidence of congenital anomalies and delayed cognitive development in their children. It has been unclear whether the increased risk of complications is due to the epilepsy per se, the use of antiepileptic drugs, or the combination of both factors. Recent studies strongly indicate an association to the medications and the dose used in pregnancy. Summary Several drugs commonly used in treatment of epilepsy are associated with increased pregnancy complications, as well as an increased risk of congenital abnormalities.
引用
收藏
页码:78 / 83
页数:6
相关论文
共 50 条
  • [1] Epilepsy in pregnancy
    Ahmed, Rehena
    Apen, Kenneth
    Endean, Coralie
    AUSTRALIAN FAMILY PHYSICIAN, 2014, 43 (03) : 112 - 116
  • [2] Overweight in epilepsy as a risk factor for pregnancy and delivery complications
    Kolstad, Eivind
    Veiby, Gyri
    Gilhus, Nils Erik
    Bjork, Marte
    EPILEPSIA, 2016, 57 (11) : 1849 - 1857
  • [3] Epilepsy in Pregnancy
    Harden, Cynthia
    Lu, Christine
    NEUROLOGIC CLINICS, 2019, 37 (01) : 53 - +
  • [4] Epilepsy and pregnancy
    Oguni, M
    Osawa, M
    EPILEPSIA, 2004, 45 : 37 - 41
  • [5] Epilepsy and pregnancy
    Gaus, Verena
    Ilyas-Feldmann, Maria
    Schmitz, Bettina
    NERVENARZT, 2024, 95 (04): : 335 - 341
  • [6] Epilepsy in Pregnancy Best Evidence for Care
    Ruth, Donna Jean
    Barnett, James
    JOURNAL OF PERINATAL & NEONATAL NURSING, 2013, 27 (03) : 217 - 224
  • [7] Differences in treatment of epilepsy in pregnancy A worldwide survey
    George, Ilena C.
    Bartolini, Luca
    Ney, John
    Singhal, Divya
    NEUROLOGY-CLINICAL PRACTICE, 2019, 9 (03) : 201 - 207
  • [8] Zonisamide safety in pregnancy: Data from the UK and Ireland epilepsy and pregnancy register
    McCluskey, G.
    Kinney, M. O.
    Russell, A.
    Smithson, W. H.
    Parsons, L.
    Morrison, P. J.
    Bromley, R.
    MacKillop, L.
    Heath, C.
    Liggan, B.
    Murphy, S.
    Delanty, N.
    Irwin, B.
    Campbell, E.
    Morrow, J.
    Hunt, S. J.
    Craig, J. J.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2021, 91 : 311 - 315
  • [9] Obstetrical complications in women with epilepsy
    Borthen, Ingrid
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2015, 28 : 32 - 34
  • [10] Pregnancy with epilepsy: Obstetric and neonatal outcome of a controlled study
    Mawer, G.
    Briggs, M.
    Baker, G. A.
    Bromley, R.
    Coyle, H.
    Eatock, J.
    Kerr, L.
    Kini, U.
    Kuzmyshcheva, L.
    Lucas, S. B.
    Wyatt, L.
    Clayton-Smith, J.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2010, 19 (02): : 112 - 119